Pritesh Shah is CCO at NovoCure Ltd (NVCR). They have made 45 open-market trades across 1 company since 2018, most recently 2023-11-07.
CIK 0001744884
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases totalling $357K since 2020, against 45 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NVCR | 124,511 | $1.8M |
Shares reported on the most recent Form 4, priced at the 2023-11-08 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NVCR | SELL · 10b5-1 | 2023-11-07 | 2023-11-08 | $12.65 | $5K | +1.0% | +3.6% | +23.2% |
| NVCR | SELL | 2023-09-01 | 2023-09-05 | $21.82 | $6K | -9.1% | -32.2% | -38.8% |
| NVCR | SELL | 2023-03-03 | 2023-03-07 | $76.16 | $3.3M | -23.5% | -15.5% | +10.6% |
| NVCR | SELL | 2023-03-02 | 2023-03-06 | $75.28 | $141K | -14.8% | -17.9% | +9.1% |
| NVCR | SELL | 2023-03-01 | 2023-03-02 | $76.36 | $294K | -11.2% | -20.6% | -5.2% |
| NVCR | SELL | 2023-01-05 | 2023-01-09 | $108.00 | $42K | -3.3% | -1.5% | -30.3% |
| NVCR | SELL | 2022-09-02 | 2022-09-06 | $79.04 | $21K | +10.6% | +8.5% | -0.8% |
| NVCR | SELL | 2022-03-09 | 2022-03-11 | $71.19 | $522K | +24.4% | +25.4% | +9.1% |
| NVCR | SELL | 2022-03-07 | 2022-03-09 | $69.73 | $1.1M | +8.0% | +18.3% | +7.9% |
| NVCR | SELL | 2022-03-03 | 2022-03-07 | $72.54 | $804K | +12.5% | +25.0% | +15.6% |
| NVCR | SELL · 10b5-1 | 2021-09-02 | 2021-09-07 | $138.57 | $91K | -5.0% | -17.8% | -39.6% |
| NVCR | SELL | 2021-08-04 | 2021-08-06 | $148.71 | $614K | -13.3% | -8.7% | -29.6% |
| NVCR | SELL | 2021-08-03 | 2021-08-04 | $149.43 | $494K | -10.7% | -9.0% | -29.3% |
| NVCR | SELL | 2021-06-10 | 2021-06-11 | $215.00 | $5.1M | +4.3% | -11.5% | -35.9% |
| NVCR | SELL | 2021-05-05 | 2021-05-06 | $199.67 | $515K | -7.8% | +7.1% | -21.7% |
| NVCR | SELL | 2021-05-04 | 2021-05-05 | $200.86 | $419K | -12.1% | +3.4% | -25.1% |
| NVCR | SELL | 2021-03-08 | 2021-03-10 | $130.97 | $1.6M | +6.1% | -0.1% | +58.8% |
| NVCR | SELL | 2021-03-05 | 2021-03-09 | $131.53 | $1.2M | +5.7% | -1.1% | +56.3% |
| NVCR | SELL | 2021-03-03 | 2021-03-05 | $143.50 | $1.4M | +13.6% | +2.1% | +60.5% |
| NVCR | SELL | 2021-03-02 | 2021-03-04 | $152.05 | $277K | +8.8% | -0.9% | +55.3% |
| NVCR | SELL | 2020-09-09 | 2020-09-11 | $85.41 | $4.8M | +17.2% | +49.0% | +86.2% |
| NVCR | BUY | 2020-09-02 | 2020-09-11 | $85.01 | $357K | +17.2% | +49.0% | +86.2% |
| NVCR | SELL | 2020-09-02 | 2020-09-11 | $85.01 | $357K | +17.2% | +49.0% | +86.2% |
| NVCR | SELL | 2020-08-03 | 2020-08-05 | $76.63 | $570K | -1.7% | +2.6% | +46.0% |
| NVCR | SELL | 2020-05-05 | 2020-05-07 | $62.20 | $143K | -2.5% | +8.7% | +20.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.